# Auro Pharmacies, Inc DBA Central Drugs – FDA Inspection, Oct 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/auro-pharmacies-inc-dba-central-drugs/f26cf1da-adc2-4b49-8b87-ea3038da9877
Source feed: FDA_Inspections

> FDA inspection 1107187 of Auro Pharmacies, Inc DBA Central Drugs, October 18, 2019. Classification: Official Action Indicated (OAI). 11 citations under 21 CFR part 211. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107187
- Company Name: Auro Pharmacies, Inc DBA Central Drugs
- Inspection Date: 2019-10-18
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 11
- Enforcement Type: AMENDED_483

## Related Documents

- [FDA Inspection 1016245 - 2017-06-29](https://www.keypedia.com/records/fda_inspections/auro-pharmacies-inc-dba-central-drugs/1cfb27f8-3a47-4170-b16b-1161a5bc6535)
- [FDA Inspection 994358 - 2016-12-02](https://www.keypedia.com/records/fda_inspections/auro-pharmacies-inc-dba-central-drugs/63e8731c-46a8-41f9-b413-152b3ad64574)

Company: https://www.keypedia.com/companies/auro-pharmacies-inc-dba-central-drugs/a406ffb6-9899-4f72-8150-c25e33323dee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c